Funded Tech Companies
Tridek-One
Tridek-One, operating out of Paris, received equity investments from Bioqube Ventures, Bpifrance and AdBio Partners.
Company Overview
Company Name
Tridek-One
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
4, Rue Thénard
Paris, 75005
FR
Paris, 75005
FR
Phone
Website
Email Address
Company Background Information
Overview
Tridek-One is a private biotechnology company founded in 2018, based on groundbreaking research by our scientific founders at INSERM, Paris on the role of CD31 in the modulation of the immune response. CD31 belongs to a family of receptors harboring immunoreceptor tyrosine-based inhibitory motifs?(ITIMs). Developing agonists for 'ITIM receptors' has the potential to restore the immune balance without immunosuppression.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/16/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laurence Schoulepnikoff
Chief Financial Officer
Régis Olivier
Company Investors
- Bioqube Ventures
- Bpifrance (Benoit Barteau)
- AdBio Partners
- Pureos Bioventures (Klaus Breiner)
- Advent Life Sciences
Browse more funded tech companies:
Tricopian | Trident Digital Group
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs